NIH-funded research Fellowship grant

Understanding how gut bacteria affect immune development in premature infants

Official title: Defining the role of premature infant microbial dysbiosis in mediating immune development and response to infection

Funded at Weill Medical Coll of Cornell Univ · NIH-10826946 · Data updated 2026-11-12

This study is looking at how the bacteria in the guts of premature babies can affect their immune systems and make them more vulnerable to infections like RSV, with the goal of finding ways to help them stay healthier.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startNovember 1, 2024
Project endOctober 31, 2027
Funding year2024
Award (this year)$85,864
NIH project number1F32HD112151-01A1
Project IDNIH-10826946 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are premature infants who are at risk for respiratory infections and related health issues.

Less likely to help

Patients who are full-term infants or those without a history of respiratory issues may not benefit from this research.

What this research studies

This research investigates the role of the gut microbiome in the immune system development of premature infants. It focuses on how changes in gut bacteria can influence the immune response to infections, particularly respiratory syncytial virus (RSV). By studying the interactions between immune cells and gut microbes, the research aims to uncover why premature infants are more susceptible to severe infections and long-term respiratory issues. The approach includes analyzing the immune responses of these infants to better understand the link between gut health and respiratory outcomes.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing respiratory infections and related complications in premature infants.

How similar studies have gone: Previous research has shown that alterations in the gut microbiome can significantly impact immune responses, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Brown, Julia — Weill Medical Coll of Cornell Univ
  • Study coordinator: Brown, Julia

Related research

Other NIH-funded projects on the same topics.

  • Microbial Dysbiosis and Its Role in Pancreatic Cancer

    A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.

    NIH research Northwestern University · Chicago, United States · NIH-11624054

  • From Symbiosis to Dysbiosis: How Resolving Inflammation Could Restore Your Mouth’s Balance

    This grant explores how turning off the harmful inflammation in periodontitis and promoting natural healing could help restore the mouth’s healthy balance.

    NIH research Ada Forsyth Institute, INC. · Somerville, UNITED STATES · NIH-11621747

  • Antibiotics, gut health, and skin reactions in kids

    A small study in children will look at whether antibiotic use and gut bacteria play a role in hives and related symptoms that children sometimes get after antibiotics.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11603169

  • Novel therapeutic to protect the gut after radiation

    A new GI-directed treatment given after radiation exposure may reduce gut damage and improve survival in people exposed to high-dose radiation.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572662

  • A new GI-focused treatment to reduce radiation damage after exposure

    A potential GI-targeted therapy given after radiation exposure may help protect the gut and improve survival in people affected by radiation injuries.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572658

  • How a mouth bacterium might fuel gum disease and heart risk

    A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11564245

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.